Marc Giroux Presents Kurve Therapeutics at LSI USA '23

Kurve brings a breakthrough approach to treat CNS disorders like Mild Cognitive Impairment, Alzheimer's, and Parkinson's. Kurve has completed Phases I, II, IIB and is Phase III ready in MCI.
Speakers
Marc Giroux
Marc Giroux
CEO, Kurve Therapeutics